← Open Payments lookup

KRISTINA WAGGONER: Open Payments

NPI 1225422231 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$768 in 36 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $768

Food & beverage: $768
CompanyPaymentsAmount
Amgen Inc.6$163
Novartis Pharmaceuticals Corporation8$151
Merck Sharp & Dohme LLC6$113
AstraZeneca Pharmaceuticals LP4$95
E.R. Squibb & Sons, L.L.C.4$71
Alnylam Pharmaceuticals Inc.2$55
AtriCure, Inc.1$29
Novo Nordisk Inc1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Esperion Therapeutics, Inc.1$17

Products named: REPATHA, LEQVIO, FARXIGA, VERQUVO, AMVUTTRA, ELIQUIS, CAPVAXIVE, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.

Industry payments across GA — which companies pay providers there.